[AAPS Advances in the Pharmaceutical Sciences Series] Global Approach in Safety Testing Volume 5 || Non-clinical Safety Studies for the Conduct of Human Clinical Trials for Pharmaceuticals: ICH M3 and M3(R2)

[AAPS Advances in the Pharmaceutical Sci

[AAPS Advances in the Pharmaceutical Sciences Series] Global Approach in Safety Testing Volume 5 || The Evolution, Scientific Reasoning and Use of ICH S2 Guidelines for Genotoxicity Testing of Pharmaceuticals

✍ van der Laan, Jan Willem; DeGeorge, Joseph J. 📂 Article 📅 2013 🏛 Springer New York ⚖ 564 KB

[AAPS Advances in the Pharmaceutical Sci

[AAPS Advances in the Pharmaceutical Sciences Series] Global Approach in Safety Testing Volume 5 || Duration of Acute and Chronic Toxicity Testing in Animals (ICH S4A and S4B)

✍ van der Laan, Jan Willem; DeGeorge, Joseph J. 📂 Article 📅 2013 🏛 Springer New York ⚖ 425 KB

[AAPS Advances in the Pharmaceutical Sci

[AAPS Advances in the Pharmaceutical Sciences Series] Global Approach in Safety Testing Volume 5 || The Value and Benefits of the International Conference on Harmonisation (ICH) to Drug Regulatory Authorities: Advancing Harmonization for Better Public Health

✍ van der Laan, Jan Willem; DeGeorge, Joseph J. 📂 Article 📅 2013 🏛 Springer New York ⚖ 109 KB

[AAPS Advances in the Pharmaceutical Sci

[AAPS Advances in the Pharmaceutical Sciences Series] Global Approach in Safety Testing Volume 5 || Toxicokinetics: A Guidance for Assessing Systemic Exposure in Toxicology Studies, Where Are We Now; An S3A/S3B Update (1995–2011)

✍ van der Laan, Jan Willem; DeGeorge, Joseph J. 📂 Article 📅 2013 🏛 Springer New York ⚖ 582 KB

Trends in sun exposure knowledge, attitu

Trends in sun exposure knowledge, attitudes, and behaviors: 1986 to 1996",June K. Robinson; Darrell S. Rigel; Rex A. Amonette 01909622,37,1997,2-part-P1,10.1016/s0190-9622(97)80119-3,CME examination," 01909622,37,1997,2-part-P1,10.1016/s0190-9622(97)80118-1,Antimicrobial agents for the dermatologist. I. β-Lactam antibiotics and related compounds,Marcia E. Epstein; Maria Amodio-Groton; Neil S. Sadick 01909622,37,1997,2-part-P1,10.1016/s0190-9622(97)80140-5,Randomized single-blind study of efficacy and tolerability of terbinafine in the treatment of tinea capitis,P. Kullavanijaya; S. Reangchainam; R. Ungpakorn 01909622,37,1997,2-part-P1,10.1016/s0190-9622(97)80143-0,Effect of topical pramoxine on experimentally induced pruritus in humans,Gil Yosipovitch; Howard I. Maibach 01909622,37,1997,2-part-P1,10.1016/s0190-9622(97)80149-1,Treatment of psoriasis with the pulsed dye laser,S.W. Lanigan; G.A. Katugampola 01909622,37,1997,2-part-P1,10.1016/s0190-9622(97)80147-8,Response rates in photopheresis therapy for cutaneous T-cell lymphoma,Herschel S. Zackheim; Mohammed Kashani-Sabet 01909622,37,1997,2-part-P1,10.1016/s0190-9622(97)80136-3,Keratosis lichenoides chronica: Response to topical calcipotriol,Marcelo H. Grunwald; Dafna Hallel-Halevy; Boaz Amichai 01909622,37,1997,1,10.1016/s0190-9622(97)70209-3,Relation between expression of adhesion molecules and clinical behavior in cutaneous follicle center cell lymphomas,Rob C. Beljaards; Peter Van Beek; Rein Willemze 01909622,37,1997,1,10.1016/s0190-9622(97)70208-1,A novel nonepidermolytic palmoplantar keratoderma: A clinical and histopathologic study of six cases,Cynthia M. Magro; Lynn A. Baden; Arthur N. Crowson; Paul E. Bowden; Howard P. Baden 01909622,37,1997,1,10.1016/s0190-9622(97)70216-0,"Tazarotene gel, a new retinoid, for topical therapy of psoriasis: Vehicle-controlled study of safety, efficacy, and duration of therapeutic effect

✍ Gerald D. Weinstein; Gerald G. Krueger; Nicholas J. Lowe; Madeleine Duvic; David 📂 Article 📅 1997 🏛 Elsevier Science 🌐 English ⚖ 765 KB